Stalled Zika Vaccine Research Shows Challenges Of Vaccine R&D
STAT: The race for a Zika vaccine slows, a setback for efforts to head off future outbreaks
“The development of a type of Zika vaccine that authorities had hoped to usher to the market has proven more challenging than some scientists and pharmaceutical companies had expected, people involved in the research have told STAT, posing a setback for efforts to avoid future outbreaks of the disease…” (Branswell, 9/13).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.